Bandaram Pharma Packtech Faces High Debt Amid Modest Profitability and Market Outperformance
Bandaram Pharma Packtech, a microcap in the Medical Equipment sector, has recently seen a change in its evaluation due to its high debt profile and flat Q3 FY24-25 performance. Despite challenges, the company reported a return on equity of 8.09% and a significant annual return of 55.59%.
Bandaram Pharma Packtech, a microcap company in the Medical Equipment/Supplies/Accessories industry, has recently undergone an adjustment in its evaluation. This revision reflects the company's current financial landscape, characterized by a high debt profile, with a debt-to-equity ratio averaging 2.78 times. Despite these challenges, Bandaram Pharma has managed to achieve a return on equity of 8.09%, indicating a modest level of profitability relative to shareholders' funds.In the latest quarter, Q3 FY24-25, the company reported flat financial performance, with earnings per share recorded at Rs -0.01. Additionally, the return on capital employed stands at 7.6, suggesting an attractive valuation with an enterprise value to capital employed ratio of 2.6. Over the past year, Bandaram Pharma has generated a notable return of 55.59%, significantly outpacing the broader market, which saw returns of 2.25%.
The stock is currently positioned within a mildly bullish range, with the majority of shares held by promoters. This context provides a comprehensive view of Bandaram Pharma Packtech's standing in the market.
Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
